You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
Mallinckrodt
Colorcon
Moodys

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Copley Pharm Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for COPLEY PHARM, and what generic and branded alternatives to COPLEY PHARM drugs are available?

COPLEY PHARM has fifteen approved drugs.



Summary for Copley Pharm
US Patents:0
Tradenames:7
Ingredients:7
NDAs:15

Drugs and US Patents for Copley Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copley Pharm ALBUTEROL SULFATE albuterol sulfate SOLUTION;INHALATION 073307-001 Nov 27, 1991 DISCN No No   Start Trial   Start Trial
Copley Pharm POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 070618-001 Sep 9, 1987 DISCN No No   Start Trial   Start Trial
Copley Pharm NABUMETONE nabumetone TABLET;ORAL 075179-001 Jun 6, 2000 DISCN No No   Start Trial   Start Trial
Copley Pharm DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 088900-002 Feb 12, 1988 DISCN No No   Start Trial   Start Trial
Copley Pharm ALBUTEROL SULFATE albuterol sulfate SOLUTION;INHALATION 073495-001 May 28, 1993 DISCN No No   Start Trial   Start Trial
Copley Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088425-001 Apr 30, 1984 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Express Scripts
Johnson and Johnson
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.